Summary:
The advent of foam sclerotherapy has been one of the most important developments in the field of phlebology. Just as surgery has evolved into more minimal invasion, so has the treatment of varicose veins. Foam sclerotherapy is quick, efficient, easy to use and inexpensive, and is widely believed to become the dominant form of therapy for varicose veins.

Foam Sclerotherapy: A Textbook explores the key role of foam in the treatment of venous insufficiency, provides authoritative and comprehensive information and examines the advantages and drawbacks of this method in detail. Written by experts from four continents, the book is divided into three sections: Theory, Practice, and Special Considerations, and includes chapters on:
• The history of sclerosant foams
• Legal guidelines
• Ultrasound guidance
• Studies on safety
• Treatment of venous malformations

Foam Sclerotherapy: A Textbook is an essential textbook for all phlebologists, general surgeons, vascular surgeons, dermatologists, family physicians and gynaecologists who treat varicose veins, either full time or occasionally.

• Foam Sclerotherapy: A Textbook explores the key role of foam in the treatment of venous insufficiency, and provides authoritative and comprehensive text reviewing the entire field

• Written by experts from four continents, including contributions from the USA, Australia, France, Germany and Japan, the book is divided into three sections: Theory, Practice and Special Considerations

• The book functions as a manual in how to utilize foam sclerotherapy as a treatment option, as well as providing an excellent overview of the current and historical literature in the field

• Chapters provide many colour figures and graphs, which enhance learning and demonstrate how to implement the technique

• Foam Sclerotherapy is an essential textbook for all phlebologists, general surgeons, vascular surgeons, dermatologists, family physicians and gynaecologists who treat varicose veins

Table of Contents:
Contributing authors
Foreword 1
Foreword 2
Preface
THEORY
1. The history of sclerosant foams: persons, techniques, patents and medical improvements
2. Dermatological manifestations of venous insufficiency
3. Sclerotherapy of varicose veins — Guidelines of the German Society of Phlebology
4. Legal guidelines for use of polidocanol and sodium tetradecyl sulfate for sclerotherapy
PRACTICE
5. The science of producing extemporary foam and its clinical results
6. Ultrasound guidance for therapeutic interventions
7. A personal method for foam sclerotherapy: technique and results
8. Foam sclerotherapy with and without duplex ultrasound guidance
9. Foam sclerotherapy for varicose veins: medium-term results as assessed by ultrasound
SPECIAL CONSIDERATIONS
10. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial
11. Ultrasound-guided foam sclerotherapy of large varicose veins
12. Transition from alcohol to foam sclerotherapy for localized venous malformations with high risk
13. Treatment of telangiectasias by sclerosing foam
14. Comparison of polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins
15. Lesser importance of the saphenous vein in varicose vein treatment
16. Efficacy of polidocanol foam compared with polidocanol liquid in sclerotherapy of venous insufficiency
17. Studies on safety of foam sclerotherapy
18. Treatment of recurrent varicose veins by sclerosant foam
19. Vascular malformations
20. Treatment of venous malformations, Klippel–Trenaunay syndrome and other low-flow lesions with foamed sclerosants
Epilogue
Index

About the Author(s):

John J Bergan MD FACS FRCS (Hon)
Vein Institute of La Jolla, CA and Department of Surgery, UCSD School of Medicine, La Jolla, CA, USA
Van Le Cheng MD
UCSD Instructor of Surgery, SD Vein Institute, Encinitas, CA, USA

Contributors:
John M Barrett MBChB FACP Palm Clinic, Auckland, New Zealand John J Bergan MD FACS FRCS (Hon) Vein Institute of La Jolla, CA and Department of Surgery, UCSD School of Medicine, La Jolla, CA, USA David Berridge DM FRCS Leeds Vascular Institute, The General Infirmary at Leeds, Leeds, UK Andrew W Bradbury BSc MB MD FRCSEd University of Birmingham, and Heart of England NHS Foundation Trust, Birmingham, UK Franz Xaver Breu MD Praxis für Gefäßmedizin am Tegernsee, Tegernsee, Germany Juan Cabrera MD PhD International Institute of Phlebology, Granada, Spain Dennis Chanter PhD Statisfaction Statistical Consultancy Ltd, Bexhill on Sea, UK Sylvain Chastanet MD Riviera Veine Institut, Nice, France Van Le Cheng MD UCSD Instructor of Surgery, SD Vein Institute, Encinitas

Readership:
Phlebologists, general surgeons, vascular surgeons, dermatologists, physicians and gynaecologists

Reviews: